Activin inhibits basal and androgen-stimulated proliferation and induces apoptosis in the human prostatic cancer cell line, LNCaP

Endocrinology

Volumn 137, Issue 12, 1996, Pages 5476-5483

  Wang, Q F ^a   Tilly, K I ^a   Tilly, J L ^a   Preffer, F ^b   Schneyer, A L ^a   Crowley Jr , William F ^a   Sluss, Patrick M ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVIN; ANDROGEN; ANDROSTANOLONE; FOLLISTATIN; GROWTH FACTOR; RECEPTOR PROTEIN;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; DNA CONTENT; HUMAN; HUMAN CELL; MALE; MALIGNANT TRANSFORMATION; MESODERM; PRIORITY JOURNAL; PROSTATE CARCINOMA;

EID: 0030444631     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/endo.137.12.8940374     Document Type: Article

References (74)

1. Vale WW, Bilezikjian LM, Rivier C 1994 Reproductive and other roles of inhibins and activins. In: Knobil E, Neill JD (eds) The Physiology of Reproduction. Raven Press, New York, pp 1861-78
2. Oda S, Nishimatsu K, Ueno N 1995 Molecular cloning and functional analysis of a new activin beta subunit: a dorsal mesoderm-inducing activity in Xenopus. Biochem Biophys Res Commun 210:581-588
3. Hotten G, Neidhardt H, Schneider C, Pohl J 1995 Cloning of a new member of the TGF-β family: a putative new activin beta-c chain. Biochem Biophys Res Commun 206:608-613
4. Ling N, Ying SY, Ueno N 1986 Pituitary FSH is released by a heterodimer of the beta-subinits from the two forms of inhibin. Nature 321:779-782
5. Vale WW, Rivier JC, Vaughan JM 1986 Purification and characterization of an FSH releasing protein from porcine ovarian follicular fluid. Nature 321:776-779
6. DePaulo LV, Bicsak TA, Erickson GF, Shimasaki S, Ling N 1991 Follistatin and activin: a potential intrinsic regulatory system within diverse tissues. Proc Soc Exp Biol Mod 198:500-512
7. Findlay JK 1993 An update on the roles of inhibin, activin, and follistatin as local regulators of folliculogenesis. Biol Reprod 48:15-23
8. Mather JP, Roberts PE, Krummen LA 1993 Follistatin modulates activin activity in a cell- and tissue-specific manner. Endocrinology 132:2732-2734
9. Michel U, Farnworth P, Findlay JK 1993 Follistatins: more than follicle-stimulating hormone suppressing proteins. Mol Cell Endocrinol 91:1-11
10. Gonzalez-Manchon C, Vale WW 1989 Activin-A, inhibin and transforming growth factor-β modulate growth of two gonadal cell lines. Endocrinology 125:1666-1672
11. de Jong FH, de Winter JP, Wesseling JG, Timmerman MA, van Genesen S, van den Eijinden-van Raaij AJM, van Zoelen JJJ 1993 Inhibin subunits, follistatin and activin receptors in the human teratocarcinoma cell line tera-2. Biochem Biophys Res Commun 192:1334-1339
12. Shikone T, Matzuk MM, Perlas E, Finegold MJ, Lewis KA, Vale WW, Bradley A, Hsueh AJW 1994 Characterization of gonadal sex cord-stromal tumor cell lines from inhibin-α and p53-deficient mice: the role of activin as an autocrine growth factor. Mol Endocrinol 8:983-995
13. DiSimone N, Crowley Jr WF, Wang QF, Sluss PM, Schneyer AL 1996 Characterisation of inhibin/activin subunit, follistatin, and activin type II receptors in human ovarian cancer cell lines: a potential role in autocrine growth regulation. Endocrinology 137:486-494
14. Matzuk MM 1995 Functional analysis of mammalian members of the transforming growth factor-beta superfamily. Trends Endocrinol Metab 6:120-127
15. Kerr JFR, Searle J 1972 A suggested explanation for the paradoxically slow-growth rate of basal-cell carcinomas that contain numerous mitotic figures. J Pathol 107:41-44
16. Williams GT 1991 Programmed cell death: Apoptosis and oncogenesis. Cell 65:1097-1098
17. Stewart BW 1994 Mechanisms of apoptosis: Integration of genetic, biochemical, and cellular indicators. J Natl Cancer Inst 86:1286-1296
18. Wyllie AH, Kerr JFR, Currie AR 1980 Cell death: the significance of apoptosis. Int Rev Cytol 68:251-306
19. Walker NI, Harmon BV, Gobe GC, Kerr JFR 1988 Patterns of cell death. Methods Achiev Exp Pathol 13:18-54
20. Ameisen JC 1996 The origin of programmed cell death. Science 1278-1279
21. Williams GT, Smith CA 1993 Molecular regulation of apoptosis: genetic controls on cell death. Cell 74:777-779
22. Kerr JFR, Winterford CM, Harmon BV 1994 Apoptosis: is significance in cancer and cancer therapy. Cancer 73:2013-2026
23. Thompson CB 1995 Apoptosis in the pathogenesis and treatment of disease. Science 267:1456-1462
24. Chen P, Yu YM, Reddi AH 1993 Chondrogenesis in chick limb bud mesodermal cells: reciprocal modulation by activin and inhibin. Exp Cell Res 206:119-127
25. Hemmati-Brivanlou A, Melton D 1992 A truncated activin receptor inhibits mesoderm induction and formation of axial structures in Xenopus embryos. Nature 359:609-613
26. Smith JC, Price BMJ, Nimmen KV 1990 Identification of a potent Xenopus mesoderm-inducing factor as a homologue of activin A. Nature 345:729-731
27. Thomsen G, Woolf T, Whitman M, Sokol S, Vaughan JM, Vale WW, Melton DA 1990 Activins are expressed early in Xenopus embryogenesis and can induce axial mesoderm and anterior structures. Cell 63:485-493
28. Hashimoto M, Kondo S, Sakurai T, Etoh Y, Shibai H, Muramatsu M 1990 Activin/EDE as an inhibitor of neural differentiation. Biochem Biophys Res Commun 173:193-200
29. Matzuk MM, Kumar TR, Vassalli A, Bickenbach JR, Roop DR, Jaenisch R, Bradley A 1995 Functional analysis of activins during mammalian development. Nature 374:354-356
30. Vassalli A, Matzuk MM, Gardner H, Lee KE, Jaenisch R 1996 Activin/inhibin beta B subunit gene disruption leads to defects in eyelid development and female reproduction. Genes Dev 8:414-427
31. Nishihara T, Okahashi N, Ueda N 1993 Activin A induces apoptotic cell death. Biochem Biophys Res Commun 197:985-991
32. Schwall RH, Robbins K, Jardieu P, Chang L, Lai C, Terrell TG 1993 Activin induces cell death in hepatocytes in vivo and in vitro. Hepatology 18:347-356
33. Koseki T, Yamamoto K, Krajewski S, Reed J, Tsujimoto Y, Nishihara T 1995 Activin A-induced apoptosis is suppressed by BCL-2. FEBS Lett 376:247-250
34. Woodruff TK, Lyon RJ, Hansen SE, Rice GC, Mather JP 1990 Inhibin and activin locally regulate rat ovarian folliculogenesis. Endocrinology 127:3196-3205
35. 3H]-thymidine uptake by rat thymocytes and 3T3 cells in vitro. Mol Cell Endocrinol 61:133-138
36. Coerver KA, Woodruff TK, Finegold MJ, Mather JP, Bradley A, Matzuk MM 1995 Activin signalling through activin receptor type II causes the cachexia-like symptoms in inhibin-deficient mice. Mol Endocrinol 536:534-543
37. Bates Y, Zhang Z, Ying SY 1995 Expression of activins and activin receptor messenger RNAs in LNCaP cells, a human prostatic adenocarcinoma cell line. Int J Oncol 6:1185-1188
38. + cells of human prostate cancer xenograft LNCaP 23 following castration. Int J Cancer 6:85-89
39. Schneyer AL, Rzucidlo DA, Sluss PM, Crowley Jr WF 1994 Characterization of unique binding kinetics of follistatin and activin or inhibin in serum. Endocrinology 135:667-674
40. Mason AJ 1994 Functional analysis of the cysteine residues of activin A. Mol Endocrinol 8:325-332
41. Tilly JL, Hsueh AJW 1993 A microscale autoradiographic method for the qualitative and quantitative analysis of apoptotic DNA fragmentation. J Cell Physiol 154:519-526
42. Tilly JL 1994 Use of the terminal transferase reaction for the biochemical and in situ analysis of apoptosis. In: Celis JE (ed) Cell Biology: A Laboratory Handbook. Academic Press, San Diego, pp 330-337
43. Rodbard D, Munson PJ, Delean A 1990 Improved curve fitting, parallelism testing, and optimization for radioligand assays. In: Rodbard D (ed) Symposium on RIA and Related Procedures in Medicine. International Atomic Energy Agency, Vienna, p 469
44. Munson PJ, Rodbard D 1980 LIGAND: a verstile computerized approach to characterization of ligand-binding systems. Anal Biochem 107:220-239
45. Lee C, Sutkowski DM, Sensibar JA 1995 Regulation of proliferation and production of prostate-specific antigen in androgen-sensitive prostatic cancer cells, LNCaP, by dihydrotestosterone. Endocrinology 136:796-803
46. Shimonaka M, Inouye S, Shimasaki S, Ling N 1991 Follistatin binds to both activin and inhibin through the common beta-subunit. Endocrinology 128:3313-3315
47. Nakamura T, Takio K, Eto Y, Shibai H, Titani K, Sugino H 1990 Activin-binding protein from rat ovary is follistatin. Science 247:836-838
48. Xiao S, Farnworth PG, Findlay JK 1992 Interaction between activin and follicle-stimulating hormone suppressing protein/follistatin in the regulation of basal inhibin production by cultured rat granulosa cells. Endocrinology 131:2365-2370
49. Demura R, Suzuki T, Tajima S, Mitsuhashi S, Odagiri E, Eto Y, Sugino H, Demura H 1992 Competitive protein binding assay for activin A/EDF using follistatin: determination of activin levels in human plasma. Biochem Biophys Res Commun 185:1148-1154
50. Hashimoto M, Shoda A, Satoshi I, Yamada R, Kondo T, Sakurai T, Ueno N, Muramatsu M 1992 Functional regulation of osteoblastic cells by the interaction of activin-A with follistatin. J Biol Chem 267:4999-5004
51. Cataldo NA, Rabinovici J, Fujimoto VY, Jaffe RB 1994 Follistatin antagonizes the effects of activin-A on steroidogenesis in human luteinizing granulosa cells. J Clin Endocrinol Metab 79:272-277
52. Sumitomo S, Inouye S, Liu X, Ling N, Shimasaki S 1995 The heparin binding site of follistatin is involved in its interaction with activin. Biochem Biophys Res Commun 208:1-9
53. Meriggiola MC, Dahl KD, Mather JP, Bremner WJ 1995 Follistatin decreases activin-stimulated FSH secretion with no effect on GnRH-stimulated FSH secretion in prepubertal male monkeys. Endocrinology 134:1967-1970
54. de Winter JP, ten Dijke P, de Vries CJM, van Achterverg TAE, Sugino H, de Waele P, Huybebroeck D, Verschueren K, van den Eijnden AJM 1996 Follistatins neutralize artivin bionctivity by inhibition of activin binding to its type II receptors. Mol Cell Endocrinol 116:105-114
55. Mathews LS 1994 Activin receptors and cellular signaling by the receptor serine kinase family. Endocr Rev 15:310-325
56. Nakamura T, Sugino K, Titani K, Sugino H 1991 Follistatin, an activin-binding protein, associates with heparan sulfate chains of proteoglycans on follicular granulosa cells. J Biol Chem 266:19432-19437
57. Wang QF, Smith PC, Crowley Jr WF, Schneyer AL, Sluss PM 1995 Activin inhibition of progesterone production by rat luteal cells in vitro. Biol Reprod 73:000 (Abstract)
58. Miro F, Hillier SG 1992 Relative effects of activin and inhibin on steroid hormone synthesis in primate granulosa cells. J Clin Endocrinol Metab 75:1556-1561
59. Xiao S, Findlay JK, Robertson DM 1990 The effect of bovine activin and follicle-stimulating hormove (FSH) suppressing protein/tollistatin on FSH-induced differentiation of rat granulosa cells in vitro. Mol Cell Endocrinol 69:1-8
60. Mather JP, Attie KM, Woodruff TK, Rice GC, Phillips DM 1990 Activin stimulates spermatogonial proliferation in germ-Sertoli cell cocultures from immature rat testis. Endocrinology 127:3206-3214
61. Boitani C, Stefanini M, Fragale A, Morena A 1995 Activin stimulates Sertoli cell proliferation in a defined period of rat testis development. Endocrinology 136:5438-5444
62. Yasuda H, Mine T, Shibata H, Hasegawa Y, Takeuchi T, Asano S, Kojima I 1993 Activin A: an autocrine inhibitor of initiation of DNA synthesis in rat hepatocytes. J Clin Invest 92:1491-1493
63. Liu QY, Niranjan B, Gomes P, Gomm JJ, Davies DR, Coombes RC, Bulnwela L 1996 Inhibitory effects of activin on the growth and morphogenesis of primary and transformed mammary epithelial cells. Cancer Res 56:1155-1163
64. Attisano L, Wrana JL, Cheifetx S, Massague J 1992 Novel activin receptors: distinct genes and alternative mRNA splicing generate a repertoire of serine/ threonine kinase receptors. Cell 68:97-108
65. Feng Z, Madigan MB 1993 Expression of type II activin receptor genes in the male and female reproductive tissues of the rat. Endocrinology 132:2593-2600
66. Bhushan A, Lin HY, Lodish HF, Kintner CR 1994 The transforming growth factor β type II receptor can replace the activin type II receptor in inducing mesoderm. Mol Cell Biol 14:251-256
67. Martens JWM, de Winter JP, Timmerman MA, McLuskey APN, de Jong FH Inhibin counteracts activin exclusively through direct interaction with the activin type II receptors. 78th Annual Meeting of The Endocrine Society, Davis, CA, 1996, p OR30-2 (Abstract)
68. Hogan B 1993 Inhibiting inhibin: mice lacking inhibin, a TGF-beta-related polypeptide, develop ovarian and testicular somatic cell tumours, suggesting that inhibin normally acts to suppress gonadal cell proliferation. Curr Biol 3:170-172
69. Liu X, Wiley S, Meikle W 1993 Androgens regulate proliferation of human prostate cancer cells in culture by increasing transforming growth factor-α (TGF-α)and epidermal growth factor (EGF)/TGF-α receptor. J Clin Endocrinol Metab 77:1472-1478
70. Berns EM, DeBoer W, Mulder E 1983 Androgen dependent growth regulation and the release of specific proteins by the androgen receptor containing human prostate tumor cell line LNCaP. Prostate 9:247-259
71. Castagnetta LA, Miceli MD, Sorci CMG, Pfeffer U, Farruggio R, Oliveri G, Calabro M, Carruba G 1995 Growth of LNCaP human prostate cancer cell is stimulated by estradiol via its own receptor. Endocrinology 136:2309-2319
72. Banerjee PP, Banerjee S, Tilly KI, Tilly JL, Brown T, Zirkin B 1995 Lobespecific apoptotic cell death in rat prostate after androgen ablation by castration. Endocrinology 136:4368-4376
73. Rittmaster RS, Manning AP, Wright AS, Thomas LN, Whitefield S, Norman RW, Lazier CB, Rowden G 1995 Evidence for atrophy and apoptosis in the ventral prostate of rats given the 5α-reductase inhibitor finasteride. Endocrinology 136:741-748
74. Furuya Y, Lin XS, Walsh JC, Nelson WG, Isaacs JT 1996 Androgen ablation-induced programmed death of prostatic glandular cells does not involve recruitment into a defective cell cycle or p53 induction. Endocrinology 136: 1898-1906